Obesity in the GLP-1 Era: Clinical Characteristics and Prescribing Patterns in a Large Integrated Health System
Preprint
Abstract
Structured Aims: To characterize adults with obesity in a large integrated health system. Methods: We created a cross-sectional cohort of adults with at least one body mass index (BMI) value >=30 kg/m2 in the prior 18 months, a recent in-person outpatient visit, and an assigned primary care provider. Electronic health record data were transformed into a patient-level analytic dataset and linked to neighborhood-level social determinants of health. Diagnoses, laboratory values, vital signs, and prescriptions were curated using reproducible phenotype definitions and internally reviewed vocabularies. Results: The registry included 280,186 adults, of whom 48% had class I obesity. The cohort was 63% female, 27% Black, and 14% lived in areas with high or very high deprivation. Common comorbidities included hypertension, type 2 diabetes, depression, and anxiety. HbA1c and cholesterol measurements were absent in more than 40% of the cohort during the prior two years. Overall, 22% of patients received a prescription for at least one weight loss drug in the past 2 years, including 18% who received a weight-loss-approved GLP-1 receptor agonist. Conclusions: This care-engaged obesity cohort was characterized by high representation of women and socially vulnerable populations, substantial cardiometabolic screening gaps, and broad adoption of GLP-1 agonists.Keywords
This publication has 34 references indexed in Scilit:
- P6 REAL-WORLD COMPARATIVE EFFECTIVENESS OF SEMAGLUTIDE 2.4 MG VERSUS OTHER COMMERCIALLY AVAILABLE MEDICATIONS FOR CHRONIC WEIGHT MANAGEMENT IN ADULTS WITH OBESITY IN THE UNITED STATES: A PRAGMATIC CLINICAL STUDYValue in Health, 2026
- Glucagon-Like Peptide-1 Receptor Agonist Order Fills and Out-of-Pocket Costs by Race, Ethnicity, and IndicationJAMA Health Forum, 2025
- Once-Weekly Semaglutide in Adults With Alcohol Use DisorderJAMA Psychiatry, 2025
- Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or ObesityJAMA Network Open, 2025
- Pragmatic Implementation of Online Obesity Treatment and Maintenance Interventions in Primary CareJAMA Internal Medicine, 2024
- Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018Obesity Science & Practice, 2023
- Effect of an Online Weight Management Program Integrated With Population Health Management on Weight ChangeJAMA, 2020
- Benefits and Risks of Bariatric Surgery in AdultsJAMA, 2020
- Depression and obesity: evidence of shared biological mechanismsMolecular Psychiatry, 2018
- Association of Hypertension, Diabetes, Dyslipidemia, and Metabolic Syndrome with Obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004Journal of the American College of Surgeons, 2008